Medycyna behawioralna – najnowsze trendy w farmakoterapii i suplementacji przy leczeniu zaburzeń zachowania kotów

Piśmiennictwo

1. Amat M., Camps T., Brech S., Manteca X.: Separation anxiety in dogs: The implications of predictability and contextual fear for behavioural treatment. „Animal Welfare”, 2014, 23.
2. Benoit S., Chaumontet C., Violle N., Boulier A., Hafeez Z., Cakir-Kiefer C., Tomé D., Schwarz J., Miclo L.: The Anxiolytic-like Properties of a Tryptic Hydrolysate of Bovine As1 Casein Containing α-Casozepine Rely on GABAA Receptor Benzodiazepine Binding Sites but Not the Vagus Nerve. „Nutrients”, 2022, 14 (11), 2212.
3. Boxenbaum H.: Comparative Pharmacokinetics of Benzodiazepines in Dog and Man. „Journal of Pharmacokinetics and Biopharmaceutics”, 1982, 10 (4), 411-26.
4. Brutlag A., Hommerding H.: Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats. „The Veterinary Clinics of North America. Small Animal Practice”, 2018, 48 (6), 1087-1102.
5. Crowell-Davis S.L.: Cognitive dysfunction in senior pets. „Compendium (Yardley, PA)”, 2008, 30 (2), 106-110.
6. Dzanis D.A.: Nutraceuticals in Veterinary Medicine. „Australian Veterinary Journal”, 1999, 77 (4), 238-39.
7. Eivani M.: Neuroscience Lab, Department of Animal Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran., Nahid Khosronezhad, and Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran. 2020. „Melissa Officinalis: A Memory Enhancer Remedy. Physiology and Pharmacology”, 2020, 24 (3), 159-64.
8. Erickson A., Harbin K., MacPherson J., Rundle K., Overall K.L.: A Review of Pre-Appointment Medications to Reduce Fear and Anxiety in Dogs and Cats at Veterinary Visits. „The Canadian Veterinary Journal. La Revue Veterinaire Canadienne”, 2021, 62 (9), 952-60.
9. Grigg E.K., Ueda Y., Walker A.L., Hart L.A., Simas S., Stern J.A.: Comparative Assessment of Heart Rate Variability Obtained via Ambulatory ECG and Polar Heart Rate Monitors in Healthy Cats: A Pilot Study. „Frontiers in Veterinary Science”, 2021, 8 (November), 741583.
10. Groce E.: The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. „Journal of Medical Regulation”, 2018, 104 (4), 32-32.
11. Jenkins T.A., Nguyen J.C.D., Polglaze K.E., Bertrand P.P.: Influence of Tryptophan and Serotonin on Mood and Cognition with a Possible Role of the Gut-Brain Axis. „Nutrients”, 2016, 8 (1), 56.
12. Kennedy D.O., Little W., Haskell C.F., Scholey A.B.: Anxiolytic Effects of a Combination of Melissa Officinalis and Valeriana Officinalis during Laboratory Induced Stress. „Phytotherapy Research: PTR”, 2006, 20 (2), 96-102.
13. Lamminen T., Korpivaara M., Suokko M., Aspegrén J., Palestrini C., Overall K.: Efficacy of a Single Dose of Pregabalin on Signs of Anxiety in Cats during Transportationv – a pilot study. „Frontiers in Veterinary Science”, 2021, 8 (September), 711816.
14. Mariti C., Guerrini F., Vallini V., Bowen J.E., Fatjó J., Diverio S., Sighieri C., Gazzano A.: The Perception of Cat Stress by Italian Owners. „Journal of Veterinary Behavior: Clinical Applications and Research: Official Journal of: Australian Veterinary Behaviour Interest Group, International Working Dog Breeding Association”, 2017, 20 (July), 74-81.
15. NIACIN and Tryptophan in Feline Nutrition. „Nutrition Reviews”, 1952, 10 (7), 207-8.
16. Overall K.: Manual of Clinical Behavioral Medicine for Dogs and Cats. Saunders. 2013.
17. Overall K.L., Dunham A.E.: Clinical features and outcome in dogs and cats with obsessive-compulsive disorder: 126 cases (1989-2000). „Journal of the American Veterinary Medical Association”, 2002, 221 (10), 1445-1452.
18. Pero M.E., Cortese L., Mastellone V., Tudisco R., Musco N., Scandurra A., D’Aniello B., Vassalotti G., Bartolini F., Lombardi P.: Effects of a Nutritional Supplement on Cognitive Function in Aged Dogs and on Synaptic Function of Primary Cultured Neurons. „Animals: An Open Access. Journal from MDPI”, 2019, 9 (7), 393.
19. Reichling J., Frater-Schröder M., Herzog K., Bucher S., Saller R.: Reduction of Behavioural Disturbances in Elderly Dogs Supplemented with a Standardised Ginkgo Leaf Extract. „Schweizer Archiv Für Tierheilkunde”, 2006, 148 (5), 257-63.
20. Riemer S., Heritier C., Windschnurer I., Pratsch L., Arhant C., Affenzeller N.: A Review on Mitigating Fear and Aggression in Dogs and Cats in a Veterinary Setting. „Animals (Basel)”, 2021, 11 (1). DOI: https://doi.org/10.3390/ani11010158.
21. 21. Riviere J.E., Papich M.G.: Veterinary Pharmacology and Therapeutics. 10^th ed. Wiley-Blackwell, 2017, 1552.
22. Roth W., Zadeh K., Vekariya R., Ge Y., Mohamadzadeh M.: Tryptophan Metabolism and Gut-Brain Homeostasis. „International Journal of Molecular Sciences”, 2021, 22 (6), 2973.
23. Rozental A.J., Gustafson D.L., Kusick B.R., Bartner L.R., Cruz Castro S., McGrath S.: Pharmacokinetics of Escalating Single-Dose Administration of Cannabidiol to Cats. „Journal of Veterinary Pharmacology and Therapeutics”, 2022. DOI: https://doi.org/10.1111/jvp.13100.
24. Selk Ghaffari M., Sabzevari A.: Successful Management of Psychogenic Alopecia with Buspirone in a Crossbreed Cat. „Comparative Clinical Pathology”, 2010, 19 (3), 317-19.
25. Tábi T., Vécsei L., Youdim M.B., Riederer P., Szökő É.: Selegiline: A Molecule with Innovative Potential. „Journal of Neural Transmission (Vienna, Austria)”, 2020, 127 (5), 831-42.
26. Tricyclic Antidepressants: In Handbook of Poisoning in Dogs and Cats, Oxford, UK: Blackwell Science Ltd., 2008, 250-53.
27. Wang T., Zakharov A., Gomez B., Lyubimov A., Trottier N.L., Schwark W.S., Wakshlag J.J.: Serum Cannabinoid 24 h and 1 Week Steady State Pharmacokinetic Assessment in Cats Using a CBD/CBDA Rich Hemp Paste. „Frontiers in Veterinary Science”, 2022, 9, 895368.

lek. wet. Martyna Woszczyło
Katedra Rozrodu
z Kliniką Zwierząt Gospodarskich
Wydział Medycyny Weterynaryjnej
Uniwersytet Przyrodniczy we Wrocławiu
pl. Grunwaldzki 49, 50-345 Wrocław